Travere Therapeutics
- Active openings
- 10+
- US-based roles
- 2
- Remote-friendly
- 2
- Last updated
- 2026-10-02
What Travere Therapeutics is hiring for
Open positions
10+ active- Associate Director, Search and EvaluationSan DiegoOct 2
- Director, Enterprise Infrastructure Engineering & OperationsSan DiegoOct 2
- Director, Clinical ScienceSan DiegoOct 2
- Director, Biologics CMC Technical WritingSan DiegoOct 1
- Associate Director, CMC Regulatory Affairs - Small MoleculesSan DiegoOct 1
About Travere Therapeutics
Claim to unlockMission, culture, and benefits - visible once this page is claimed and verified.
Updates
Travere to Present New Data Supporting FILSPARI® (sparsentan) as Foundational Treatment in IgA Nephropathy and FSGS at ASN Kidney Week 2026
Travere Therapeutics Receives Notice of Allowance from the U.S. Patent and Trademark Office for U.S. Patent Application Directed to Certain Methods of Using FILSPARI® (sparsentan) in Focal Segmental Glomerulosclerosis
Travere Therapeutics Announces Planned Chief Executive Officer Transition
Travere Therapeutics to Present at the Stifel 2026 Virtual Immunology and Inflammation Forum
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)